Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence
about
Effect of combined naltrexone and bupropion therapy on the brain's reactivity to food cuesA preliminary study of the human brain response to oral sucrose and its association with recent drinking.Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference BehaviorDietary sugars: their detection by the gut-brain axis and their peripheral and central effects in health and diseases.Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependenceAcute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial.Emotional graphic cigarette warning labels reduce the electrophysiological brain response to smoking cues.Putting the brakes on the "drive to eat": Pilot effects of naltrexone and reward-based eating on food cravings among obese womenNaltrexone alters the processing of social and emotional stimuli in healthy adultsOpioidergic and dopaminergic manipulation of gambling tendencies: a preliminary study in male recreational gamblers.A preference test for sweet taste that uses edible strips.Opioid system and human emotions.Effects of injectable extended-release naltrexone (XR-NTX) for opioid dependence on residential rehabilitation outcomes and early follow-up.Sustained opioid antagonism modulates striatal sensitivity to baby schema in opioid use disorder.Effects of naltrexone on food intake and body weight gain in olanzapine-treated rats.Opiate agonists and antagonists modulate taste perception in opiate-maintained and recently detoxified subjects.Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder.The effect of naltrexone on body fat mass in olanzapine-treated schizophrenic or schizoaffective patients: a randomized double-blind placebo-controlled pilot study.
P2860
Q30438802-411F11C1-6D4F-4616-B714-BA86F6753C99Q30654466-F2EA6366-3511-4A15-8568-8A109241797DQ34501087-C7940140-A82E-4B16-9F13-A9BBFA8F8E83Q35003062-E72043D2-1C94-4996-A069-874A86F94E97Q35161399-FA0FF4E4-45F6-4F4F-B81E-90CABBC1079DQ35799698-6ADB75CF-EBE9-4136-BED7-745A01F21F72Q35822123-72C9DCE5-6402-43A6-ACC4-0A38F14AC339Q36278840-078BB61B-D462-45F6-9085-E8FD6D486F1BQ37119755-1ADC7A29-0480-4C61-920B-9210603245CDQ37217415-2BC4F1D2-7901-40C2-99C1-66EA3948C500Q37641614-E9BA1B5E-EA06-4C25-83B9-CA746796C3CEQ39231627-E0811A93-B066-45EC-A9F7-B5320D0B3856Q41474014-B3CC865B-8759-427D-9582-FD4058D772E6Q44351026-C672CE44-0458-4BFC-B75B-EA09A6FD8E33Q47302385-0893AF57-259E-452A-BC96-97A59E5C09F0Q50484679-2719CFF9-AD0F-49FB-8BBD-AD73ACB9092AQ51747087-8E67AC8A-6862-4305-9537-F8271F96CD71Q54620826-F4BAE489-3C5A-4DD5-8181-7F6270366A90
P2860
Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Depot naltrexone decreases rew ...... atients with opioid dependence
@ast
Depot naltrexone decreases rew ...... atients with opioid dependence
@en
type
label
Depot naltrexone decreases rew ...... atients with opioid dependence
@ast
Depot naltrexone decreases rew ...... atients with opioid dependence
@en
prefLabel
Depot naltrexone decreases rew ...... atients with opioid dependence
@ast
Depot naltrexone decreases rew ...... atients with opioid dependence
@en
P2860
P1433
P1476
Depot naltrexone decreases rew ...... atients with opioid dependence
@en
P2093
Charles P O'Brien
Daniel D Langleben
P2860
P2888
P304
P356
10.1007/S00213-011-2503-1
P577
2011-09-30T00:00:00Z